The pro-tumor role for SWI/SNF defined is distinct from its role as a tumor suppressor as described previously in other cancers, including common ARID1A loss-of-function mutations in ovarian clear cell carcinoma [44–46]. Here, SMARCA1 is linked to neoplasm.